InvestorsHub Logo
Boards
News
Market Data
Markets
Discover
Discover
Subscribe Login/Register
S&P 500
5,214.08
(
0.51%
)
US TECH 100
17,628.40
(
0.15%
)
Dow Jones
39,387.76
(
0.85%
)
Brent Oil
84.02
(
0.54%
)
Bitcoin
62,569.33
(
2.26%
)
Post# of 21531
Next 10
Reply Private New
Public Reply Private Reply New Post
Keep Last Read
Keep Next 10 Report Keyboard Shortcuts
Next 10 Prev Next

XenaLives

Send PM Follow Ignore
Followers 481
Posts 60461
Boards Moderated 18
Alias Born 09/20/2001

XenaLives

Member Level

Re: Whoopddew post# 10638

Tuesday, 05/21/2019 10:52:28 AM

Tuesday, May 21, 2019 10:52:28 AM

Post# of 21531
But there are no studies whatsoever showing that Bryostatin will work on earlier stage disease. There are also no long term safety studies for Byostatin.

2-73 has a safety study going into its fifth year with 21 of 32 original participants in the P2a.



In Peace, In War

Public Reply Private Reply New Post
Keep Last Read
Keep Last Read Next 10 Report Keyboard Shortcuts
Next 10 Prev Next
Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Detailed Quote
Recent SNPX News
More SNPX News
InvestorsHub NewsWire

VAYK Discloses Strategic Conversation on Potential Acquisition of $4 Million Home Service Business • VAYK • May 9, 2024 9:00 AM

Bantec's Howco Awarded $4.19 Million Dollar U.S. Department of Defense Contract • BANT • May 8, 2024 10:00 AM

Element79 Gold Corp Successfully Closes Maverick Springs Option Agreement • ELEM • May 8, 2024 9:05 AM

Kona Gold Beverages, Inc. Achieves April Revenues Exceeding $586,000 • KGKG • May 8, 2024 8:30 AM

Epazz plans to spin off Galaxy Batteries Inc. • EPAZ • May 8, 2024 7:05 AM

Moon Equity Holdings, Corp. Announces Acquisition of Wikolo, Inc. • MONI • May 7, 2024 9:48 AM

Start posting your company's news
Only $200 per official company press release!